Ticker Details
Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd is a pharmaceutical company which develops, produces and markets generic and specialty medicines which include chemical and therapeutic medicines in a variety of dosage forms and central nervous system medicines.
IPO Date:	March 26, 1990
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$39.85B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.38 | 1.32%
Avg Daily Range (30 D):	$0.46 | 1.37%
Avg Daily Range (90 D):	$0.36 | 1.27%

Institutional Daily Volume
Avg Daily Volume:	7.75M
Avg Daily Volume (30 D):	8.36M
Avg Daily Volume (90 D):	9.19M

Trade Size
Avg Trade Size (Sh.):	238
Avg Trade Size (Sh.) (30 D):	127
Avg Trade Size (Sh.) (90 D):	149

Institutional Trades
Total Institutional Trades:	80,690
Avg Institutional Trade:	$2.3M
Avg Institutional Trade (30 D):	$4.34M
Avg Institutional Trade (90 D):	$4.03M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	14

Market Closing Trades
Avg Closing Trade:	$5.62M
Avg Closing Trade (30 D):	$18.3M
Avg Closing Trade (90 D):	$15.62M
Avg Closing Volume:	265.79K

News

Feb 23, 2026 @ 1:48 PM FDA Accepts Teva's New Long-Acting Schizophrenia T... Source: Vandana Singh

Feb 20, 2026 @ 7:43 PM U.S. Food and Drug Administration (FDA) Accepts Te... Source: Not Specified

Feb 17, 2026 @ 12:04 PM Teva Pharmaceutical's New Study Shows Lasting Reli... Source: Vandana Singh

Feb 17, 2026 @ 11:00 AM Teva and Sanofi’s duvakitug phase 2b mainte... Source: Na

Feb 17, 2026 @ 11:00 AM Press Release: Sanofi and Teva’s duvakitug ... Source: Sanofi And Teva

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$1.23	$.42	$1.23
Diluted EPS	$1.21	$.41	$1.21
Revenue	$17.26B	$1.5B	$17.26B
Gross Profit	$8.94B	$2.66B	$8.94B
Net Income / Loss	$1.42B	$481M	$1.42B
Operating Income / Loss	$2.16B	$300M	$2.16B
Cost of Revenue	$8.32B	$2.06B	$8.32B
Net Cash Flow	$256M	$1.35B	$256M
PE Ratio	28.03

Splits
Jul 01, 2004	2:1
Dec 06, 2002	2:1
Feb 23, 2000	2:1